VYNE VYNE Therapeutics Inc. logo

VYNE VYNE Therapeutics Inc.

Healthcare
$0.67-0.96%ClosedMarket Cap: $11.2M

As of 2026-05-25

Insider Statistics (Q1 2026)

Acquisitions

0

Dispositions

4

Buy/Sell Ratio

0.00

Net Shares

-25,122

Shares Acquired

0

Shares Disposed

25,122

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu Apr 02Zeronda Tylerofficer: CHIEF FINANCIAL OFFICERSell4,007$0.6099,788
Thu Apr 02Stuart Iainofficer: CHIEF SCIENTIFIC OFFICERSell2,876$0.60112,363
Thu Apr 02Harsch Mutyaofficer: CHIEF LEGAL OFFICER AND GCSell4,007$0.60121,898
Thu Apr 02Domzalski Daviddirector, officer: PRESIDENT AND CEOSell14,232$0.60401,976
Mon Jan 05Zeronda Tylerofficer: CHIEF FINANCIAL OFFICERSell7,858$0.58103,795
Mon Jan 05Stuart Iainofficer: CHIEF SCIENTIFIC OFFICERSell2,448$0.58115,239
Mon Jan 05Harsch Mutyaofficer: CHIEF LEGAL OFFICER AND GCSell3,579$0.58125,905
Mon Jan 05Domzalski Daviddirector, officer: PRESIDENT AND CEOSell12,684$0.58416,208
Mon Dec 15Little Elisabeth SandovaldirectorSell20,000$0.3820,000
Mon Dec 15LEPORE PATRICK GdirectorSell20,000$0.3820,000
Mon Dec 15Basta Steven LdirectorSell20,000$0.3820,000
Mon Dec 15BARBARI SHARONdirectorSell20,000$0.3820,000
Thu Oct 02Zeronda Tylerofficer: CHIEF FINANCIAL OFFICERSell3,420$0.34111,653
Thu Oct 02Stuart Iainofficer: CHIEF SCIENTIFIC OFFICERSell2,453$0.34117,687